Optimal threshold of time interval from symptom onset to diagnosis for identification of severity and outcomes in acute symptomatic pulmonary embolism

急性症状性肺栓塞严重程度和预后识别中,从症状出现到确诊的最佳时间间隔阈值

阅读:1

Abstract

BACKGROUND: The more severe the pulmonary embolism (PE), the shorter the time interval from PE symptom onset to diagnosis (OTD). Nevertheless, it is not known how many days of OTD is the optimal threshold for the identification of severe PE or what differences exist in outcomes among PE patients classified by this threshold. METHODS: Patients with acute symptomatic PE were retrospectively studied to determine the optimal OTD threshold for identifying the severity and outcomes of PE. The differences in one-year mortality, VTE recurrence, major bleeding, and composite outcomes among patients with PE classified by this threshold were compared. RESULTS: A total of 1878 patients with PE were finally obtained. All patients were divided into the short OTD (OTD ≤ 1day) group (N = 736) and long OTD (OTD > 1day) group (N = 1142), based on the acquired OTD threshold of one day. The short OTD group had more shock (20.7% vs. 2.9%), hypoxia (62.8% vs. 34.0%), and cardiac arrest (9.2% vs. 1.2%) at PE diagnosis than the long OTD group (all p < 0.001). The occurrence of one-year all-cause mortality (21.7% vs. 16.5%, p = 0.004), PE-related mortality (7.9% vs. 1.9%, p < 0.001), and composite outcomes (28.7% vs. 23.0%, p = 0.006) in the short OTD group were more than that in the long OTD group. In multivariable analyses, OTD > 1day was correlated with a decreased risk of high-risk PE (OR 0.263 [0.117-0.591], p = 0.001) and one-year composite outcomes (HR 0.812 [0.677-0.974], p = 0.025), compared with OTD ≤ 1day. CONCLUSIONS: PE patients with OTD ≤ 1day had more high-risk PE and worse one-year clinical outcomes, compared to those with OTD > 1day. An OTD of one day could be the optimal threshold for the identification of severity and outcomes of PE.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。